Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InspireMD (NSPR) EPS (Weighted Average and Diluted) (2022 - 2025)

InspireMD's EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.12 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 33.33% year-over-year to -$0.12; the TTM value through Dec 2025 reached -$0.77, changed 0.0%, while the annual FY2025 figure was -$0.76, 0.0% changed from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.12 in Q4 2025 per NSPR's latest filing, up from -$0.17 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.12 in Q4 2025 to a low of -$0.6 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 4 years is -$0.29, with a median of -$0.22 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): surged 78.33% in 2023, then plummeted 38.46% in 2024.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.6 in 2022, then soared by 78.33% to -$0.13 in 2023, then crashed by 38.46% to -$0.18 in 2024, then surged by 33.33% to -$0.12 in 2025.
  • Per Business Quant, the three most recent readings for NSPR's EPS (Weighted Average and Diluted) are -$0.12 (Q4 2025), -$0.17 (Q3 2025), and -$0.26 (Q2 2025).